AASLD Practice Guideline

You have free access to this content

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases†‡§

  1. Marc G. Ghany1,¶,*,
  2. David R. Nelson2,
  3. Doris B. Strader3,
  4. David L. Thomas4,
  5. Leonard B. Seeff5

Article first published online: 26 SEP 2011

DOI: 10.1002/hep.24641

Issue

Hepatology

Hepatology

Volume 54, Issue 4, pages 1433–1444, October 2011

Additional Information

How to Cite

Ghany, M. G., Nelson, D. R., Strader, D. B., Thomas, D. L. and Seeff, L. B. (2011), An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 54: 1433–1444. doi: 10.1002/hep.24641

Author Information

  1. 1

    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

  2. 2

    Section of Hepatobiliary Disease, University of Florida, Gainesville, FL

  3. 3

    Gastroenterology and Hepatology Division, Fletcher Allen Health Care, University of Vermont College of Medicine, Burlington, VT

  4. 4

    Johns Hopkins Medical Institution, Baltimore, MD

  5. 5

    The Hill Group, Bethesda, MD

  1. fax: 301-402-0491

*Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 9B-16, 10 Center Drive, MSC 1800, Bethesda, MD 20892-1800

  1. †

    Potential conflict of interest: Dr. Nelson receives research support from Vertex, Merck, Phamassett, Genentech/Roche, Gilead, Bristol-Myers Squibb, Tibotec, Bayer/Onyx and serves on advisory boards of Merck, Pharmassett, Genentech/Roche, Gilead, Tibotec, and Bayer/Onyx, and is a consultant for Vertex.Dr. Thomas receives research support from Merck, Gilead and serves on a Merck advisory board.Dr. Ghany, Dr. Seeff, and Dr. Strader have nothing to report.

  2. ‡

    Consultant in Hepatology for the U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20943. The views expressed in the document are those of the authos and not of the Food and Drug Administration.

  3. §

    All AASLD Practice Guidelines are updated annually. If you are viewing a Practice Guideline that is more than 12 months old, please visit www.aasld.org for an update in the material.

  4. fax: 301-402-0491

Publication History

  1. Issue published online: 27 SEP 2011
  2. Article first published online: 26 SEP 2011
  3. Accepted manuscript online: 2 SEP 2011 09:28AM EST
  4. Manuscript Received: 29 AUG 2011
  5. Manuscript Accepted: 29 AUG 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS